Paid Clinical Trials District of Columbia
Discover 798 paid clinical trials in District of Columbia. Search by city or condition to find a research study near you that matches your needs across various therapeutic areas.
Elacestrant, CombinationOpen-Label Umbrella Study To Evaluate Safety And Efficacy Of Elacestrant In Various Combination In Patients With Metastatic Breast Cancer
Sponsor:
Stemline Therapeutics, Inc.
Location:
Code:
NCT05563220
Conditions
Breast Cancer
Metastatic Breast Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Elacestrant
Alpelisib
Everolimus
Ribociclib
Palbociclib
Observational StudyA Longitudinal Observational Study of Patients Undergoing Therapy for IMISC
Sponsor:
Target PharmaSolutions, Inc.
Location:
Code:
NCT03661866
Conditions
Atopic Dermatitis
Alopecia Areata
Hidradenitis Suppurativa
Vitiligo
Psoriasis
Eligibility Criteria
Sex: All
Age: 0 - 70+
Healthy Volunteers: Not accepted
Total Ablative TherapyTesting the Addition of Total Ablative Therapy to Usual Systemic Therapy Treatment for Limited Metastatic Colorectal Cancer, the ERASur Study
Sponsor:
Alliance for Clinical Trials in Oncology
Location:
Code:
NCT05673148
Conditions
Metastatic Colorectal Adenocarcinoma
Stage IV Colorectal Cancer AJCC V8
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Stereotactic Ablative Radiotherapy
Resection
Microwave Ablation
Chemotherapy
Computed Tomography
TrastuzumabSTOP-HER2: Stopping Trastuzumab in HER2+ MBC
Sponsor:
Dana-Farber Cancer Institute
Location:
Code:
NCT05721248
Conditions
Breast Cancer
Metastatic Breast Cancer
HER2-positive Breast Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Cessation of anti-HER2 treatment
Giredestrant vs. FulvestrantA Study to Evaluate Efficacy and Safety of Giredestrant Compared With Fulvestrant (Plus a CDK4/6 Inhibitor), in Participants With ER-Positive, HER2-Negative Advanced Breast Cancer Resistant to Adjuvant Endocrine Therapy (pionERA Breast Cancer)
Sponsor:
Hoffmann-La Roche
Location:
Code:
NCT06065748
Conditions
Estrogen Receptor-Positive, HER2-Negative Advanced Breast Cancer
Eligibility Criteria
Sex: All
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Giredestrant
Fulvestrant
Abemaciclib
Palbociclib
Ribociclib
Luveltamab Tazevibulin vs. IC ChemotherapyREFRaME-O1: A Study to Investigate the Efficacy and Safety of Luveltamab Tazevibulin Versus Investigator's Choice (IC) Chemotherapy in Women With Ovarian Cancer (Including Fallopian Tube or Primary Peritoneal Cancers) Expressing FOLR1
Sponsor:
Sutro Biopharma, Inc.
Location:
Code:
NCT05870748
Conditions
Ovarian Cancer
Epithelial Ovarian Cancer
Fallopian Tube Cancer
Primary Peritoneal Cancer
Platinum-resistant Ovarian Cancer
Eligibility Criteria
Sex: Female
Age: 18+
Healthy Volunteers: Not accepted
Interventions
Luveltamab tazevibulin
Pegfilgrastim
Gemcitabine
Paclitaxel
Pegylated liposomal doxorubicin
Manual ManipulationPost-Procedural Manual Manipulation for Infant Ankyloglossia
Sponsor:
Georgetown University
Location:
Code:
NCT06830148
Conditions
Ankyloglossia
Breastfeeding Support
Eligibility Criteria
Sex: All
Age: 0 - 70+
Healthy Volunteers: Not accepted
Interventions
Post-frenotomy manual manipulation
Nutritional InterventionNutritional Intervention for Endometriosis
Sponsor:
Physicians Committee for Responsible Medicine
Location:
Code:
NCT05175248
Conditions
Endometriosis
Eligibility Criteria
Sex: Female
Age: 18 - 45
Healthy Volunteers: Not accepted
Interventions
Plant-based Intervention Group
IptacopanEfficacy and Safety of Iptacopan (LNP023) in Adult Patients With Atypical Hemolytic Uremic Syndrome Naive to Complement Inhibitor Therapy
Sponsor:
Novartis Pharmaceuticals
Location:
Code:
NCT04889430
Conditions
Atypical Hemolytic Uremic Syndrome
Eligibility Criteria
Sex: All
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Iptacopan
EmpagliflozinEffect of Empagliflozin on Podocyte Specific Proteins in African American Veterans With NDKD
Sponsor:
Washington D.C. Veterans Affairs Medical Center
Location:
Code:
NCT06110130
Conditions
Chronic Kidney Diseases
Eligibility Criteria
Sex: All
Age: 19 - 70+
Healthy Volunteers: Not accepted
Interventions
Empagliflozin 10 MG
Placebo